| James Von Beattie, DO | |
|
400 Medical Plz, Suite 100, Lake St Louis, MO 63367-1490 | |
| (636) 639-8600 | |
| (636) 639-8676 |
| Full Name | James Von Beattie |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 400 Medical Plz, Lake St Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508829177 | NPI | - | NPPES |
| P00050149 | Other | RR MEDICARE | |
| 189526 | Other | GHP | |
| 647447 | Other | HEALTHLINK | |
| 180221 | Other | MO | BCBS |
| 3600531 | Other | UHC | |
| 209118108 | Medicaid | MO | |
| 7833546 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2000158289 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm St Joseph Hospital West | Lake saint louis, MO | Hospital |
| Ssm St Joseph Health Center | Saint charles, MO | Hospital |
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Medical Group Inc | 6608776299 | 491 |
News Archive
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
In a step toward better diagnosis and treatment of digestive conditions, such as inflammatory bowel disease, scientists report in ACS Biomaterials & Engineering that they have developed a first-of-its-kind collagen-based membrane for use in microchips.
Older adults who regularly take part in word and number puzzles have sharper brains, according to the largest online study to date.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 8 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
In a step toward better diagnosis and treatment of digestive conditions, such as inflammatory bowel disease, scientists report in ACS Biomaterials & Engineering that they have developed a first-of-its-kind collagen-based membrane for use in microchips.
Older adults who regularly take part in word and number puzzles have sharper brains, according to the largest online study to date.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Von Beattie, DO Po Box 955534, Saint Louis, MO 63195-5534 Ph: () - | James Von Beattie, DO 400 Medical Plz, Suite 100, Lake St Louis, MO 63367-1490 Ph: (636) 639-8600 |
News Archive
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
In a step toward better diagnosis and treatment of digestive conditions, such as inflammatory bowel disease, scientists report in ACS Biomaterials & Engineering that they have developed a first-of-its-kind collagen-based membrane for use in microchips.
Older adults who regularly take part in word and number puzzles have sharper brains, according to the largest online study to date.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 8 days ago
John David Wilkes, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 400 Medical Plz, Suite 100, Lake St Louis, MO 63367 Phone: 636-639-8600 Fax: 636-639-8676 | |
Michael J Zerega, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Brevco Plz, Suite 208, Lake St Louis, MO 63367 Phone: 636-561-9020 Fax: 636-561-6208 | |
Dr. Piotr T Dyk, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Harbor Bend Ct Ste 227, Lake St Louis, MO 63367 Phone: 636-443-2440 Fax: 636-443-2486 | |
Melissa Amy Grizzle, FNP-BC Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 107 Brevco Plz, Lake St Louis, MO 63367 Phone: 636-561-8100 Fax: 636-561-3396 | |
Priyanka Tiwari, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Brevco Plz Ste 208, Lake St Louis, MO 63367 Phone: 636-561-9020 | |
Dr. Paul Barto Vatterott, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 107 Brevco Plz, Lake St Louis, MO 63367 Phone: 636-561-8100 Fax: 636-561-3396 | |
Umesh C. Inampudi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Plz, Lake St Louis, MO 63367 Phone: 314-317-0600 Fax: 314-317-0606 |